Imig JD - Search Results

1

Eicosanoids and renal damage in cardiometabolic syndrome.

Imig JD. Imig JD. Expert Opin Drug Metab Toxicol. 2008 Feb;4(2):165-74. doi: 10.1517/17425255.4.2.165. Expert Opin Drug Metab Toxicol. 2008. PMID: 18248310 Free PMC article. Review.

2

Eicosanoids and renal vascular function in diseases.

Imig JD. Imig JD. Clin Sci (Lond). 2006 Jul;111(1):21-34. doi: 10.1042/CS20050251. Clin Sci (Lond). 2006. PMID: 16764555 Review.

3

Cardiovascular therapeutic aspects of soluble epoxide hydrolase inhibitors.

Imig JD. Imig JD. Cardiovasc Drug Rev. 2006 Summer;24(2):169-88. doi: 10.1111/j.1527-3466.2006.00169.x. Cardiovasc Drug Rev. 2006. PMID: 16961727 Review.

4

Targeting epoxides for organ damage in hypertension.

Imig JD. Imig JD. J Cardiovasc Pharmacol. 2010 Oct;56(4):329-35. doi: 10.1097/FJC.0b013e3181e96e0c. J Cardiovasc Pharmacol. 2010. PMID: 20531214 Free PMC article. Review.

5

Epoxide hydrolase and epoxygenase metabolites as therapeutic targets for renal diseases.

Imig JD. Imig JD. Am J Physiol Renal Physiol. 2005 Sep;289(3):F496-503. doi: 10.1152/ajprenal.00350.2004. Am J Physiol Renal Physiol. 2005. PMID: 16093425 Free article. Review.

J Biol Chem 276: 36059-36062, 2001) and we (Imig JD, Falck JR, Wei S, and Capdevila JH. J Vasc Res 38: 247-255, 2001; Imig JD, Zhao X, Capdevila JH, Morisseau C, and Hammock BD. Hypertension 39: 690-694, 2002; Zhao X, Pollock DM, Inscho EW, Zeldin DC, …

J Biol Chem 276: 36059-36062, 2001) and we (Imig JD, Falck JR, Wei S, and Capdevila JH. J Vasc Res 38: 247-255, 2001; Imig …

6

Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

Olearczyk JJ, Quigley JE, Mitchell BC, Yamamoto T, Kim IH, Newman JW, Luria A, Hammock BD, Imig JD. Olearczyk JJ, et al. Among authors: imig jd. Clin Sci (Lond). 2009 Jan;116(1):61-70. doi: 10.1042/CS20080039. Clin Sci (Lond). 2009. PMID: 18459944 Free PMC article.

7

Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension.

Manhiani M, Quigley JE, Knight SF, Tasoobshirazi S, Moore T, Brands MW, Hammock BD, Imig JD. Manhiani M, et al. Among authors: imig jd. Am J Physiol Renal Physiol. 2009 Sep;297(3):F740-8. doi: 10.1152/ajprenal.00098.2009. Epub 2009 Jun 24. Am J Physiol Renal Physiol. 2009. PMID: 19553349 Free PMC article.

8

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Imig JD, Hammock BD. Imig JD, et al. Nat Rev Drug Discov. 2009 Oct;8(10):794-805. doi: 10.1038/nrd2875. Nat Rev Drug Discov. 2009. PMID: 19794443 Free PMC article. Review.

9

CYP450, COX-2 and Obesity Related Renal Damage.

Imig JD, Zhao X, Dey A, Shaw M. Imig JD, et al. Toxicol Mech Methods. 2005;15(2):125-36. doi: 10.1080/15376520590918856. Toxicol Mech Methods. 2005. PMID: 20021073

10

Cytochrome P450 eicosanoids and cerebral vascular function.

Imig JD, Simpkins AN, Renic M, Harder DR. Imig JD, et al. Expert Rev Mol Med. 2011 Mar 1;13:e7. doi: 10.1017/S1462399411001773. Expert Rev Mol Med. 2011. PMID: 21356152 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page